The Hidden Costs of Discount Cards: Understanding Copay Accumulator Adjustment
By Emma Ryan
Our deep dive into coupon policies that may affect how much you pay for prescriptions – updated for 2019
Recently, certain employers, insurers, and pharmacy benefit managers (the “middlemen” between drug manufacturers and insurance companies) have instituted rules to try to discourage the use of discount coupons, also called copay cards. Many health plans are no longer counting these coupons toward deductibles and out-of-pocket maximums as part of a new practice called “accumulator adjustment.”
Discount coupons help many people with diabetes afford their medication. People often receive coupons from physicians, through advertisements, or via online searches. At the pharmacy, these coupons can reduce out-of-pocket costs – sometimes by hundreds of dollars. Some coupons have eligibility criteria, but others are open to anyone who has a prescription.
Typically, these coupons decrease the out-of-pocket cost of the medication while counting the original, higher price toward an individual’s deductible (the yearly amount you pay before insurance kicks in). People have traditionally been able to reach their deductible or out-of-pocket maximum using the money that drug manufacturers contribute via these coupons. This is why accumulator adjustment policies are extremely damaging for people who rely on discount coupons for medications with no generic equivalent.
Here’s how accumulator adjustment works:
Say your pharmacy deductible is $500, which is typical here in California for a Bronze insurance plan.
The cost of the medication is $100, but a copay card brings down the amount you pay to $5, with the remainder paid by the drug’s manufacturer. Under traditional policy, the full cost of the drug – $100 – would be counted toward your deductible, even though you’ve only paid $5 of your own money.
The situation is much worse under accumulator adjustment. Since you’ve only paid $5 out-of-pocket, only $5 is counted toward your $500 deductible. With the addition of these policies, many people who use discount cards – particularly those with high deductibles – will end up paying more for their supplies. For background on why these polices are being implemented, click here.
What can you do about this?
1. Be informed.
People who have benefited from these coupons in the past may not even be aware of the change, so the first step is to find out if this policy change applies to you. To avoid any surprises when meeting your 2019 deductible, check your plan’s most recent benefits documents. Though some plans transparently list new accumulator programs in a user-friendly “Summary of Benefits” document, others do not. And, each health insurance plan refers to accumulator adjustment in different ways. Below are what some large health groups are calling the new policy:
United Healthcare calls this “Coupon Adjustment: Benefit Plan Protection”
CVS Caremark calls it “True Accumulation”
Express Scripts calls it “Out of Pocket Protection”
Find up-to-date benefits documents on your health plan’s website and searching for keywords like “coupon,” “copay card,” “accumulation,” and “accumulator.”
You can also call your health insurer directly. Here is a sample script:
“I’ve heard that there are new programs that do not allow for my prescription co-pay card to be applied to my deductible as it was in the past. This program is called copay accumulator adjustment. Are you adopting these programs or do you have future plans to adopt this program?”
2. Investigate if switching health plans can help save you money.
A lower deductible plan, though it may have higher premiums (cost of plan), could reduce costs in the long run. See our guide to maintaining coverage while changing plans here. If this is not an option, here are some additional resources on access and affordability:
Ten tips for saving money on diabetes care
Patient assistance programs for insulins and other diabetes medications
3. Get involved with patient advocacy groups.
There are patient advocacy groups that are pushing back on these policy changes. If you believe that these new policies are harmful to your health, DPAC (Diabetes Patient Advocacy Coalition) offers resources for taking action on impending bills in Indiana and Virginia. (These two bills would ban accumulator adjustment on all medications, not just medications without a lower-cost substitute.)
Why are these policies being instituted?
While discount coupons help individuals afford medication, they can drive up costs for everyone in the long term if they cause people to switch from less expensive generics or biosimilars (the term used to mean “generic” when specifically talking about insulin) to more expensive brand name medications. Typically, insurers encourage people to use low-cost medications by offering lower copays for generic and biosimilar equivalents. Insurers have an incentive to do this because it means they pay less for these drugs, too. When coupons allow people to afford more expensive medications, however, the insurer pays more to the manufacturer. This can ultimately translate to higher premiums for everyone on the health plan. Medicare prohibits copay coupons for this reason, and California prohibits copay coupons for medications that have a lower-cost generic equivalent for all California residents.
Beyond encouraging use of more expensive medications, many argue that copay cards allow manufacturers to raise the prices of these medications. When coupons make drugs affordable to consumers, manufacturers are given room to raise prices without impacting demand. Ultimately, insurers pay the difference. A 2016 study found that among 23 brand name medications for which there was a generic equivalent available, coupons increased overall spending by an average of between $6 million to $24 million per year.
In diabetes, however, there are fewer brand name medications with lower-cost generics available. In fact, a recent study found that 50% of drugs with copay cards available had no generic equivalent or close substitute. Copay accumulator adjustment programs impact all drugs, even the ones without a less expensive substitute.
This article is part of a series on access that was made possible by support from Lilly Diabetes. The diaTribe Foundation retains strict editorial independence for all content.